CD8A and neoplasm: PD-L1 inhibits cytokine production and the cytolytic activity of PD-1 + , tumor-infiltrating CD4 + and CD8 + T cells [44, 47]; conversely, inhibition of the PD‐1/PD‐L1 axis has produced impressive response rates in various cancer types.